Masimo Corp (NASDAQ:MASI) (Trend Analysis) shares were traded with more than 50% increase in usual volume. The stock closed last trading session at $60.47, up by 5.75%, with a volume of 767,832 shares against an average amount for the last three months of 341,691.
Stock Performance: Click here for a free comprehensive Trend Analysis Report
Masimo Corp (NASDAQ:MASI) stock is currently trading 0.56% below its 52-week-high, 83.08% above its 52-week-low. The 1-year stock price history is in the range of $33.03 – $60.81. Masimo Corp (MASI) has a price to earnings ratio of 31.71 versus Healthcare sector average of 40.79. MASI stock price has outperformed the Nasdaq by 43.3%. The Patient Monitoring Equipment company is currently valued at $2.98 billion, and its share price closed the last trading session at $60.47. The stock has a 50-day moving average of $58.6 and a 200-day moving average of $53.7.
Masimo Corp (MASI) current short interest stands at 875.25 million shares. It has decreased by 5% from the same period of last month. Around 1962% of the company’s shares, which are float, are short sold. With a 10-days average volume of 0.6 million shares, the number of days required to cover the short positions stand at 1465.4 days.
Masimo Corp (MASI) declared last quarter earnings on November 02. The Patient Monitoring Equipment company announced last quarter earnings per share of $0.47 against a consensus Street estimate of $0.42, beating the average estimate by $0.05. The company posted a revenue of $167.6 million compared to an estimation of $165.8 million.
Is this a Trading Opportunity? Click here for a free Trend Analysis Report
There are currently seven analysts that cover Masimo Corp stock. Of those seven, four have a Buy rating, three have a Hold rating. On a consensus basis this yields to an Overweight rating. The consensus target price stands at $59.6.
A recent analyst activity consisted of Piper Jaffray reiterating their Overweight stance on August 4. Piper Jaffray increased their price target on MASI from $52 to $55. This corresponds to a 9.05% downside from the last closing price. On the date of report, the stock closed at $57.43.
Wedbush reiterated their Outperform stance on the same day, and increased their price target on MASI stock from $60 to $63. This corresponds to a 4.18% upside from the last closing price. On the date of report, the stock closed at $57.43.
Masimo Corp (MASI) has a debt to equity ratio of 41% compared to Healthcare sector average of 70%. The company has a current ratio of 2.46. This ratio should be higher than one (ideally two) and is an indicator to show if the company is able to finance its short term obligations. Indeed, it should have higher short term assets to dispose in order to cover for its short term liabilities.
Masimo Corporation designs, develops and licenses medical signal processing and sensor technology for the noninvasive monitoring of physiological parameters. The Company’s first products are designed to improve the effectiveness of pulse oximetry by overcoming the inability of current monitors to precisely measure the levels of arterial blood oxygen saturation and low arterial blood flow.